COMBINATION CHEMOTHERAPY FOR MYELOMATOSIS

被引：3
|
作者：
CLARKE, M
GRAY, R
DUNN, J
MACLENNAN, I
机构：
[1] UNIV OXFORD,RADCLIFFE INFIRM,IMPERIAL CANC RES FUND,CANC STUDIES UNIT,OXFORD OX2 6HE,ENGLAND
[2] UNIV BIRMINGHAM,SCH MED,CLIN RES CTR,TRIALS UNIT,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[3] UNIV BIRMINGHAM,SCH MED,DEPT IMMUNOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
来源：
LANCET | 1992年 / 340卷 / 8816期
关键词：
D O I：
10.1016/0140-6736(92)91520-I
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：433 / 433
页数：1
相关论文
共 50 条
  • [1] CHEMOTHERAPY IN MYELOMATOSIS
    INNES, J
    NEWALL, J
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1963, 56 (08): : 648 - 650
  • [2] COMBINATION THERAPY FOR MYELOMATOSIS
    AZAM, L
    DELAMORE, IW
    BRITISH MEDICAL JOURNAL, 1974, 4 (5944): : 560 - 564
  • [3] CHEMOTHERAPY OF MULTIPLE MYELOMATOSIS
    不详
    LANCET, 1947, 253 (SEP13): : 395 - 396
  • [4] RADIOTHERAPY CHEMOTHERAPY IN MANAGEMENT MYELOMATOSIS
    INNES, J
    NEWALL, J
    QUARTERLY JOURNAL OF MEDICINE, 1965, 34 (136): : 490 - &
  • [5] STANDARD CHEMOTHERAPY FOR MYELOMATOSIS - AN AREA OF GREAT CONTROVERSY
    BOCCADORO, M
    PILERI, A
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) : 371 - 382
  • [6] COMBINED CHEMOTHERAPY WITH ABCM VERSUS MELPHALAN FOR TREATMENT OF MYELOMATOSIS
    MACLENNAN, ICM
    CHAPMAN, C
    DUNN, J
    KELLY, K
    LANCET, 1992, 339 (8787): : 200 - 205
  • [7] COMBINED CHEMOTHERAPY VERSUS MELPHALAN AND PREDNISOLONE FOR TREATMENT OF MYELOMATOSIS
    GREGORY, WM
    RICHARDS, MA
    MALPAS, JS
    LANCET, 1992, 339 (8805): : 1353 - 1354
  • [8] SPINAL-CORD COMPRESSION IN MYELOMATOSIS - RESPONSE TO CHEMOTHERAPY ALONE
    SINOFF, CL
    BLUMSOHN, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02): : 197 - 200
  • [9] MULTIPLE MYELOMATOSIS TREATED WITH A COMBINATION OF URETHANE AND AN ORAL NITROGEN MUSTARD
    INNES, J
    RIDER, WD
    BLOOD, 1955, 10 (03) : 252 - 258
  • [10] MYELOMATOSIS
    不详
    LANCET, 1948, 252 (SEP25): : 499 - 500
12345